These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38529074)

  • 1. Weakly Supervised Detection of Pheochromocytomas and Paragangliomas in CT.
    Oluigbo DC; Santra B; Mathai TS; Mukherjee P; Liu J; Jha A; Patel M; Pacak K; Summers RM
    ArXiv; 2024 Feb; ():. PubMed ID: 38529074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weakly supervised detection of pheochromocytomas and paragangliomas in CT using noisy data.
    Oluigbo D; Mathai TS; Santra B; Mukherjee P; Liu J; Jha A; Patel M; Pacak K; Summers RM
    Comput Med Imaging Graph; 2024 Sep; 116():102419. PubMed ID: 39053035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weakly-Supervised Detection of Bone Lesions in CT.
    Sheng T; Mathai TS; Shieh A; Summers RM
    Proc SPIE Int Soc Opt Eng; 2024 Feb; 12927():. PubMed ID: 38974478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weakly-Supervised Detection of Bone Lesions in CT.
    Sheng T; Mathai TS; Shieh A; Summers RM
    ArXiv; 2024 Jan; ():. PubMed ID: 38529078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative Management of Pheochromocytomas and Sympathetic Paragangliomas.
    Fagundes GFC; Almeida MQ
    J Endocr Soc; 2022 Feb; 6(2):bvac004. PubMed ID: 35128297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Noortman WA; Vriens D; de Geus-Oei LF; Slump CH; Aarntzen EH; van Berkel A; Timmers HJLM; van Velden FHP
    Eur Radiol; 2022 Oct; 32(10):7227-7236. PubMed ID: 36001126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas.
    Snezhkina A; Pavlov V; Dmitriev A; Melnikova N; Kudryavtseva A
    Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance.
    Calissendorff J; Juhlin CC; Bancos I; Falhammar H
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas.
    Mete O; Pakbaz S; Lerario AM; Giordano TJ; Asa SL
    Am J Surg Pathol; 2021 Sep; 45(9):1264-1273. PubMed ID: 33826547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a novel nomogram predicting pseudohypoxia type pheochromocytomas and paragangliomas.
    Wang Y; Liu L; Chen D; Pang Y; Xu X; Liu J; Li M; Guan X
    J Endocrinol Invest; 2023 Jul; 46(7):1361-1371. PubMed ID: 36508127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytomas and paragangliomas.
    Yen K; Lodish M
    Curr Opin Pediatr; 2021 Aug; 33(4):430-435. PubMed ID: 34039901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Diagnosis to Therapy-PET Imaging for Pheochromocytomas and Paragangliomas.
    Patel HV; Srivastava A; Becker MD; Beninato T; Laird AM; Singer EA
    Curr Urol Rep; 2021 Jan; 22(1):2. PubMed ID: 33403502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Reinforcement Learning for Weakly-Supervised Lymph Node Segmentation in CT Images.
    Li Z; Xia Y
    IEEE J Biomed Health Inform; 2021 Mar; 25(3):774-783. PubMed ID: 32749988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of spot urinary free metanephrines and 3-methoxytyramine with internal reference correction for the diagnosis of pheochromocytomas and paragangliomas.
    Wang H; Zhang X; Zhen Q; Zou W; Chen H; Luo C; Ding M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1156():122306. PubMed ID: 32829134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas.
    Gabiache G; Zadro C; Rozenblum L; Vezzosi D; Mouly C; Thoulouzan M; Guimbaud R; Otal P; Dierickx L; Rousseau H; Trepanier C; Dercle L; Mokrane FZ
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical management of pheochromocytoma and paraganglioma in Singapore: missed opportunities for genetic testing.
    Chew WHW; Courtney E; Lim KH; Li ST; Chen Y; Tan MH; Chung A; Khoo J; Loh A; Soh SY; Iyer P; Loh LM; Ngeow J
    Mol Genet Genomic Med; 2017 Sep; 5(5):602-607. PubMed ID: 28944243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High specificity of spot urinary free metanephrines in diagnosis and prognosis of pheochromocytomas and paragangliomas by HPLC with electrochemical detection.
    Zuo M; Zhen Q; Zhang X; Zou W; Yang X; Tian G; Shi Z; Li Q; Ding M
    Clin Chim Acta; 2018 Mar; 478():82-89. PubMed ID: 29273559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
    Kim KY; Kim JH; Hong AR; Seong MW; Lee KE; Kim SJ; Kim SW; Shin CS; Kim SY
    PLoS One; 2016; 11(12):e0168413. PubMed ID: 27992508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas.
    Zhao L; Zhang T; Meng X; Zhang Z; Zhou Y; Fan H; Liu Y; Zhou X; Zhu H
    Ann Med; 2023 Dec; 55(1):2203945. PubMed ID: 37129505
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.